Achyut Healthcare share price
BSE: 543499Pharmaceuticals & BiotechnologySmall Cap
Last close ₹6.96up ₹0.33 (4.98%)
Share price at the BSE close on 23 Oct 2026. Previous close ₹6.63.
52-week range of traded prices to 23 Oct 2026
₹4.70Low, 13 May 2026₹10.04High, 24 Jun 2026
- Under BSE's short-term additional surveillance, stage I, on the list for 22 Oct 2026. The exchange puts a share here when its price has moved unusually, and trading in it carries extra conditions.
- Next results date: the board meets on 26 Oct 2026 to consider: quarterly results.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹168 Cr2,685th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit.
- No recent results
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet.
- No recent results
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- Volume, BSEVolume. Shares traded on the last trading day.
- 40,407
Results
Standalone; ₹ crore, the charts by years to March, the table by quarter.Quarterly results
Quarter to Jun 2026, against the quarter beforeFiled 13 Aug
- RevenueRevenue. The pill is the change in revenue against the quarter before: this period's figure divided by that one's, less one, in per cent.
- ₹3.13 Crdown 28.70%
- Net profitNet profit. The pill is the change in net profit against the quarter before: this period's figure divided by that one's, less one, in per cent.
- ₹0.14 Crup 152.38%
- Net marginNet margin. Net profit as a percentage of revenue: how much of each rupee of sales is left after every cost, interest and tax.
- 4.6%
Revenue by year
Peak revenue ₹12 Cr, year to Mar 2026
Net profit by year, a loss in red
| ₹ crore | Dec 2025Filed 21 Jan | Mar 2026Filed 27 May | Jun 2026Filed 13 Aug |
|---|---|---|---|
| Revenue | 1.57 | 4.39 | 3.13 |
| Net profit | 0.00 | 0.06 | 0.14 |
| Net marginNet margin. Net profit as a percentage of revenue: how much of each rupee of sales is left after every cost, interest and tax. | 0.3% | 1.3% | 4.6% |
Standalone. The 3 quarters from Dec 2025, the first on record; the half years before them are below. The latest is shaded.
| ₹ crore | Sep 2024Filed 11 Nov | Mar 2025Filed 30 May | Sep 2025Filed 17 Oct |
|---|---|---|---|
| Revenue | 2.13 | 0.92 | 5.64 |
| Net profit | 0.35 | 0.20 | 0.23 |
| Net marginNet margin. Net profit as a percentage of revenue: how much of each rupee of sales is left after every cost, interest and tax. | 16.6% | 21.2% | 4.1% |
Standalone. The half years in the same span that the quarters on record do not fully cover.
Business segments
In the year to Mar 2026 the company reports one business segment, Pharmaceuticals, which carries all its revenue.
Where the return came from
Yearly rates to Mar 2026, per-share figures restated for splits and bonuses.
| Over | Return a year | Earnings growth | Change in P/E | Dividend yield |
|---|---|---|---|---|
| 1 year | +61.7% | −43.7% | +187.3% | 0.0% |
| 3 years | +26.5% | +3.6% | +22.1% | 0.0% |
Return is price growth plus the average dividend yield. Change in P/E is (1 + price growth) / (1 + earnings growth) - 1, so the parts compound rather than add. Earnings growth over 1 and 3 years is on profit divided by shares in issue at both ends: the earnings per share stated for one end does not match that year's profit and share count.
Peers and competitors
Pharmaceuticals, 216 listed companies, priced on 23 Oct 2026. The table lists the 8 companies closest to Achyut Healthcare in market cap.
Achyut Healthcare is not on the chart: it has no P/E or return on equity today
| Company | |||||||||
|---|---|---|---|---|---|---|---|---|---|
 Coral LaboratoriesCORALAB | 177 | 9.2 | 0.8 | 5.8 | −5.4% | +7.2% | 9.4% | 7.6% | 0.40% |
 Kerala AyurvedaKERALAYUR | 171 | – | 15.3 | – | +10.4% | – | −257.3% | −24.1% | 0.00% |
 Brooks LaboratoriesBROOKS | 170 | 12.9 | 1.4 | 29.4 | −7.7% | +550.4% | 12.0% | 3.2% | 0.00% |
 Oxygenta PharmaceuticalOXYGENTAPH | 170 | – | – | – | +20.6% | – | – | −15.1% | 0.00% |
 Syschem (India)SYSCHEM | 166 | – | – | – | +59.1% | – | – | 11.7% | 0.00% |
 Medico RemediesMEDICO | 165 | 12.0 | 2.2 | 10.4 | +50.0% | +33.7% | 20.1% | 15.3% | 0.00% |
 Smruthi OrganicsSMRUTHIORG | 153 | 20.7 | 2.1 | 8.5 | −4.6% | +118.2% | 10.2% | 14.8% | 1.12% |
 Natural CapsulesNATCAPSUQ | 149 | – | 0.7 | – | +8.8% | – | −9.5% | −5.2% | 0.00% |
Market cap in ₹ crore. Growth is the last twelve months against the twelve before. A figure is left empty where it would rest on a loss or the company has under a year of results on record. ROE is the shareholders' profit over their net worth. ROCE is profit before interest and tax over the whole group's net worth plus borrowings, as in the figures at the top of the page.
Latest announcements
Routine notices left out.Share news and announcements
Oct 2026
21 Oct · Board meeting
Meeting on 26 Oct 2026: quarterly results
Sep 2026
Achyut Healthcare share price by year
Each calendar year to 2025.Achyut Healthcare share price history
| Year | Close at year end | Change | Highest close | Lowest close |
|---|---|---|---|---|
| 2025 | 5.50 | +38.9% | 6.51 | 2.96 |
| 2024 | 3.96 | −4.4% | 5.96 | 2.87 |
| 2023 | 4.14 | +246.6% | 4.18 | 1.25 |
| 2022 | 1.20 | – | 1.40 | 0.81 |
₹ per share, adjusted for splits and bonuses since. Change is on the close at the end of the year before. 2023 is from its first session, 30 Jan 2023. 2022 is from its first session, 30 Mar 2022.
Recent sessions
The last 10 trading days to 23 Oct 2026, as traded on BSE.
| Date | Open | High | Low | Close | Average price | Volume |
|---|---|---|---|---|---|---|
| 23 Oct 2026 | 6.96 | 6.96 | 6.96 | 6.96 | 6.96 | 40,407 |
| 22 Oct 2026 | 6.63 | 6.63 | 6.63 | 6.63 | 6.63 | 12,921 |
| 21 Oct 2026 | 6.32 | 6.32 | 6.32 | 6.32 | 6.32 | 45,477 |
| 19 Oct 2026 | 6.02 | 6.02 | 6.02 | 6.02 | 6.02 | 2,65,372 |
| 16 Oct 2026 | 5.74 | 5.74 | 5.50 | 5.74 | 5.73 | 72,388 |
| 15 Oct 2026 | 5.30 | 5.47 | 5.07 | 5.47 | 5.40 | 85,099 |
| 14 Oct 2026 | 5.00 | 5.22 | 4.89 | 5.21 | 5.17 | 83,334 |
| 13 Oct 2026 | 5.29 | 5.29 | 4.97 | 4.98 | 5.01 | 1,40,840 |
| 12 Oct 2026 | 5.67 | 5.67 | 5.20 | 5.23 | 5.35 | 99,834 |
| 9 Oct 2026 | 5.74 | 5.74 | 5.39 | 5.47 | 5.61 | 22,614 |
Prices in ₹ per share as traded, not adjusted.
Price adjustments
What the price chart is corrected for, so it reads as one share held throughout.Bonus shares and stock split history
| Ex-date | Event | Price factor | What happened |
|---|---|---|---|
| 10 Dec 2024 | Bonus | 0.7143 | Holders received 2 bonus shares for every 5 held. |
| 10 Dec 2024 | Split | 0.1000 | Each share became 10. |
| 25 Apr 2023 | Bonus | 0.6667 | Holders received 1 bonus share for every 2 held. |
Earlier prices are multiplied by the factor, so the chart reads as one share held throughout.
Company details
- Legal name
- Achyut Healthcare Limited
- BSE code
- 543499
- ISIN
- INE0K1401020
- Industry
- Pharmaceuticals & Biotechnology
- Listed
- Mar 2022
- Face value
- ₹1
- CIN
- L67120GJ1996PLC028600
- Corporate identity number, the registrar of companies' code for it